文献速递外周血管心血管介入DSA

剂量管理系统集成的三维皮肤剂量图与辐射变色胶片临床评估比较

Clinical evaluation of a dose management system-integrated 3D skin dose map by comparison with radiochromic films.
PubMed 文献 · Eur Radiol · 2020-04-24

研究纳入98例接受腹盆腔栓塞或计划冠状动脉血管成形术的患者,用辐射变色胶片验证辐射剂量管理系统(RDMS)估算的峰值皮肤剂量(PSD)与皮肤剂量图。RDMS与胶片测值一致性良好(一致性相关系数0.94),但RDMS估算的PSD显著高估5%–9%,导致需随访患者数量增加。剂量图在多数患者匹配,差异与透视时检查床位移及楔形滤过器使用有关。

要点

  • RDMS皮肤剂量图工具可自动估算PSD和皮肤剂量分布,约束少于辐射变色胶片。
  • RDMS估算的PSD较胶片测值显著高估5%–9%,可能增加需随访患者数量。
  • 剂量图差异主要与透视时检查床位移及楔形滤过器使用有关,DICOM辐射剂量结构化报告未涵盖这些因素。

核心结论

  • RDMS皮肤剂量图工具可为所有患者计算PSD和皮肤剂量分布,约束少于辐射变色胶片,但估算的PSD被高估,增加了需随访的患者数量。

研究设计与样本

  • 研究为临床验证研究,2018年6月至2019年3月连续筛查288例接受腹盆腔栓塞或计划冠状动脉血管成形术并使用辐射变色胶片的患者,最终纳入98例(69名男性,平均年龄66±14岁)。
  • PSD通过辐射变色胶片测量(PSDFilm),并由RDMS使用一个平板模体和两个拟人模体计算(PSDRDMS)。
  • 采用Lin一致性相关系数评估统计一致性,Bland-Altman图评估临床一致性,配对Mann-Whitney-Wilcoxon检验比较数值。

关键影像表现/征象

  • PSDFilm中位数(第1;第3四分位数)为0.59 Gy(0.40;1.08)。
  • PSDRDMS平板模体为0.62 Gy(0.43;1.22),拟人模体为0.62 Gy(0.42;1.19)。
  • 剂量图表现在多数患者中匹配,识别出的差异归因于透视事件中检查床位移和楔形滤过器的使用。

诊断标准与关键数值

  • PSDFilm与PSDRDMS的一致性良好:平板模体一致性相关系数0.94(0.91;0.95),拟人模体0.94(0.91;0.96)。
  • 血管手术中,PSDRDMS较PSDFilm显著增加5%(-4%;16%)[平板模体,p=0.001]和7%(-6%;22%)[拟人模体,p=0.002]。
  • 心脏手术中,PSDRDMS较PSDFilm显著增加9%(-4%;26%)[平板模体,p=0.01]和6%(-4%;23%)[拟人模体,p=0.02]。
  • 所有手术中,估算的PSD显著高于测量的PSD:平板模体高5%(-4%;18%)(p<0.001),拟人模体高6%(-5%;22%)(p<0.001)。

临床应用与阅片要点

  • RDMS皮肤剂量图工具可用于自动估算PSD和皮肤剂量分布,但需注意其高估PSD可能导致更多患者被要求随访。
  • 阅片和报告时需考虑透视过程中检查床位移及楔形滤过器使用对剂量图准确性的影响,这些因素未在DICOM辐射剂量结构化报告中体现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To validate the performance of an automatic tool to estimate a patient's peak skin dose (PSD) and a skin dose map from data collected by a radiation dose management system (RDMS) during interventional procedures.

METHODS: In total, 288 eligible consecutive patients undergoing abdominopelvic embolisation or planned coronary angioplasty using radiochromic films were screened between June 2018 and March 2019. For 98 included patients, PSD was measured using radiochromic films (PSDFilm) and computed by RDMS (PSDRDMS) using one flat and two anthropomorphic phantoms. Statistical concordance between PSDFilm and PSDRDMS was computed with Lin's concordance correlation coefficient and clinical concordance with the Bland and Altman graphic; values were compared using the paired Mann-Whitney-Wilcoxon test.

RESULTS: In total, 190/288 patients were excluded and 98 patients were analysed (69 men, mean age 66 ± 14 years). The PSDFilm median (1st; 3rd quartile) was 0.59 Gy (0.40; 1.08). PSDRDMS was 0.62 Gy (0.43; 1.22) for the flat phantom and 0.62 Gy (0.42; 1.19) for anthropomorphic phantoms. The concordance between PSDFilm and PSDRDMS was good for both phantoms (flat: 0.94 [0.91; 0.95]; anthropomorphic 0.94 [0.91; 0.96]). Compared with the values of PSDFilm, the values of PSDRDMS were significantly increased by 5% (- 4%; 16%) for flat phantom (p = 0.001) and 7% (- 6%; 22%) for anthropomorphic phantoms (p = 0.002) for vascular procedures and 9% (- 4%; 26%, p = 0.01) and 6% (- 4%; 23%, p = 0.02) for cardiac procedures, respectively. Dose map representations matched for most patients. The gaps identified were due to table displacement during fluoroscopy events and the use of a wedge filter.

CONCLUSIONS: The RDMS skin dose map tool allowed the computation of the PSD and skin dose distribution for all patients with fewer constraints than radiochromic films. However, the computed PSD was overestimated, increasing the number of patients requiring follow-up.

KEY POINTS: • A good concordance correlation was identified between the peak skin dose (PSD) values measured with radiochromic films and estimated with the radiation dose management system (RDMS) skin dose map tool. • Differences were related to table displacement during fluoroscopy events and the use of a wedge filter, which are not accounted in the Digital Imaging and Communications in Medicine Radiation Dose Structured Reports. • For all procedures, the estimated PSDs were significantly higher than the measured PSDs by 5% (- 4%; 18%) for flat phantom (p < 0.001) and 6% (- 5%; 22%) for anthropomorphic phantoms (p < 0.001).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Greffier J, Grussenmeyer-Mary N, Hamard A, et al. Clinical evaluation of a dose management system-integrated 3D skin dose map by comparison with radiochromic films. Eur Radiol. 2020. PMID: 32333144. doi:10.1007/s00330-020-06877-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。